| Scientific Name |
Tixagevimab, Cilgavimab
|
|---|---|
| Brand Name |
Evusheld
|
| Risk |
"Updated dosage recommendations for EVUSHELD (tixagevimab co-packaged with cilgavimab) for pre-exposure prophylaxis against COVID-19 High-risk cardiac patients and the use of EVUSHELD (tixagevimab co packaged with cilgavimab) Risk of cardiovascular events"
|
| Educational Materials for Healthcare Professionals |
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Educational Materials for Patients |
|